Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2026-03-08 @ 12:31 AM
Study NCT ID:
NCT00470535
Status:
TERMINATED
Last Update Posted:
2017-02-23
First Post:
2007-05-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000543406
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None